These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10940916)

  • 21. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen.
    Lehner T; Tao L; Panagiotidi C; Klavinskis LS; Brookes R; Hussain L; Meyers N; Adams SE; Gearing AJ; Bergmeier LA
    J Virol; 1994 Mar; 68(3):1624-32. PubMed ID: 8107223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innate and adaptive mucosal immunity in protection against HIV infection.
    Bergmeier LA; Lehner T
    Adv Dent Res; 2006 Apr; 19(1):21-8. PubMed ID: 16672545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection.
    Bogers WM; Bergmeier LA; Oostermeijer H; ten Haaft P; Wang Y; Kelly CG; Singh M; Heeney JL; Lehner T
    Vaccine; 2004 Aug; 22(23-24):2974-84. PubMed ID: 15356916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of route of immunization on mucosal immunity and protection.
    Lehner T; Wang Y; Ping L; Bergmeier L; Mitchell E; Cranage M; Hall G; Dennis M; Cook N; Doyle C; Jones I
    J Infect Dis; 1999 May; 179 Suppl 3():S489-92. PubMed ID: 10099126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of macaque gammadelta + T cells in lymphoid compartments after rectal infection with SIVsmmPBj14.
    Chen ZW; Shen Y; Davis IC; Shen L; Letvin NL; Fultz PN
    J Med Primatol; 2000 Aug; 29(3-4):143-7. PubMed ID: 11085576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal alloimmunization elicits T-cell proliferation, CC chemokines, CCR5 antibodies and inhibition of simian immunodeficiency virus infectivity.
    Bergmeier LA; Babaahmady K; Wang Y; Lehner T
    J Gen Virol; 2005 Aug; 86(Pt 8):2231-2238. PubMed ID: 16033970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
    Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production.
    Gauduin MC; Glickman RL; Ahmad S; Yilma T; Johnson RP
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14031-6. PubMed ID: 10570193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route.
    Lehner T; Brookes R; Panagiotidi C; Tao L; Klavinskis LS; Walker J; Walker P; Ward R; Hussain L; Gearing JH
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8638-42. PubMed ID: 7690967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates.
    Lehner T; Bergmeier LA; Tao L; Panagiotidi C; Klavinskis LS; Hussain L; Ward RG; Meyers N; Adams SE; Gearing AJ
    J Immunol; 1994 Aug; 153(4):1858-68. PubMed ID: 7519218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
    Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
    Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homing of mononuclear cells from iliac lymph nodes to the genital and rectal mucosa in non-human primates.
    Mitchell EA; Bergmeier LA; Doyle C; Brookes R; Hussain LA; Wang Y; Lehner T
    Eur J Immunol; 1998 Oct; 28(10):3066-74. PubMed ID: 9808175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous production of RANTES and antigen-specific IFN-gamma production in macaques vaccinated with SHIV-4 correlates with protection against SIVsm challenge.
    Ahmed RK; Makitalo B; Karlen K; Nilsson C; Biberfeld G; Thorstensson R
    Clin Exp Immunol; 2002 Jul; 129(1):11-8. PubMed ID: 12100017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate immunity in experimental SIV infection and vaccination.
    Ahmed RK; Biberfeld G; Thorstensson R
    Mol Immunol; 2005 Feb; 42(2):251-8. PubMed ID: 15488612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
    Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses.
    Malkevitch NV; Patterson LJ; Aldrich MK; Wu Y; Venzon D; Florese RH; Kalyanaraman VS; Pal R; Lee EM; Zhao J; Cristillo A; Robert-Guroff M
    Virology; 2006 Sep; 353(1):83-98. PubMed ID: 16814356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of simian immunodeficiency virus infection on immune inductive and effector sites in the rectal mucosa of rhesus macaques.
    Vajdy M; Veazey RS; Knight HK; Lackner AA; Neutra MR
    Am J Pathol; 2000 Aug; 157(2):485-95. PubMed ID: 10934152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
    J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal Th1- versus Th2-type responses for antibody- or cell-mediated immunity to simian immunodeficiency virus in rhesus macaques.
    McGhee JR; Kiyono H; Kubota M; Kawabata S; Miller CJ; Lehner T; Imaoka K; Fujihashi K
    J Infect Dis; 1999 May; 179 Suppl 3():S480-4. PubMed ID: 10099124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.